ARCHIVES

Phase II Study Finds Dasatinib May Overcome ALL Resistance

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

Klausner To Serve As Advisor On Bioterrorism For NAS.

January 4, 2002

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

Cancer Letter On Vacation

August 3, 1984

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

March 27, 2009